'I don't know where that number will end up – my guess is it'll be lower than the 20% we've done,' Marcus Frampton says, referring to the venture allocation within the overall PE allocation.
Wiz’s success could incentivize more cybersecurity start-ups to focus on addressing AI risks, which could help reduce companies’ trepidation about fully integrating AI into their workflows.
Michael Fosnaugh discusses the Model N deal and Vista's strategy.
Better understanding the costs to integrate cybersecurity solutions into clients’ operations will enable VCs to improve the chances of portfolio companies capturing more market share, says Justin Somaini, YL Ventures' newest partner.
Pro rata participation rights (otherwise known as pro rata rights) are a venture capital investor’s one true superpower, says Steve Brotman of Alpha Partners.
The venture capital firm invests in pre-Series A technology companies in the agriculture and food supply chain.
The firm is seeking $400m for NewView Capital Fund III and $300m for NewView Capital Special Opportunities Fund III.
The Swedish firm spent two years fundraising in an 'undeniably challenging' market, says partner Johanna Levander.
Forbion, a life sciences venture capital firm, has held a first close on €75m for Forbion BioEconomy Fund I, which is targeting €150m.
Index Ventures has raised $800 million for its 12th venture fund and $1.5 billion for its seventh growth fund.